Unraveling the interplay between iron homeostasis, ferroptosis and extramedullary hematopoiesis

Abstract

Iron participates in myriad processes necessary to sustain life. During the past decades, great efforts have been made to understand iron regulation and function in health and disease. Indeed, iron is associated with both physiological (e.g., immune cell biology and function and hematopoiesis) and pathological (e.g., inflammatory and infectious diseases, ferroptosis and ferritinophagy) processes, yet few studies have addressed the potential functional link between iron, the aforementioned processes and extramedullary hematopoiesis, despite the obvious benefits that this could bring to clinical practice. Further investigation in this direction will shape the future development of individualized treatments for iron-linked diseases and chronic inflammatory disorders, including extramedullary hematopoiesis, metabolic syndrome, cardiovascular diseases and cancer.

Keywords: Amlodipine; Artesunate; Cancer; Deferasirox; Deferoxamine; Dexrazoxane; Doxorubicin; Erastin; Extramedullary hematopoiesis; Ferritinophagy; Ferroptosis; Inflammation; Iron; Metabolic syndrome; Nifedipine; Quercetin; RSL3.